Medindia

X

Reportlinker Adds Cancer Therapeutics: Market Insight & Pipeline Analysis

Friday, November 6, 2009 General News J E 4
Advertisement


NEW YORK, Nov. 5 Reportlinker.com announces that a new market research report is available in its catalogue.

Cancer Therapeutics: Market Insight & Pipeline Analysis

http://www.reportlinker.com/p0158345/Cancer-Therapeutics-Market-Insight--Pipeline-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Objectives and Scope

The intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics. This report analyzes in detail the markets for colorectal cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin's lymphoma. Therapies for other types of cancer are discussed throughout the report, but are limited to the Company Briefs chapter and various tables throughout the report. This report examines these major cancer markets in light of newly emerging therapeutics, shifting market shares and line extensions for major products on the market.

Reason for this study

The overall economic cost of cancer is staggering. The US National Institutes of Health (NIH) estimates overall costs of cancer in the U.S. in 2006 at $206.3 billion with $78.2 billion in direct medical costs. Further the WHO predicts that global cases of cancer will rise to 15 million new cases by 2020, an increase of 50% over 2005's rate. These staggering numbers indicate the importance of effective therapies in treating this epidemic. There is today still a strong need for therapies that more specifically target cancer cells extend progression-free survival rates provide patients with metastatic cancer better treatment options

What questions does this report answer

What is the current market status of cancer therapeutics in general and with regard to specific types of cancer?

What are the strengths, weaknesses, opportunities and threats facing various cancer therapeutics already on the market and ones still in the clinic?

What are the major issues involved in the research and development of more effective cancer therapeutics?

Which new cancer therapeutics in development are nearing the market? And how are they performing in the clinic?

Key features of this Report

Market analysis of cancer therapeutics, by product, class, cancer type, region/country and company

SWOT (strengths, weaknesses, opportunities, threats) analysis for key products on the market as well as for key emerging products

A thorough overview of treatment regimens for various cancers, including detailed information and analysis of first-line, second-line and third-line treatment options

Financial forecasts, by individual cancer therapy and cancer type

Explanations of key technologies and mechanism of action of new classes of cancer drugs

Thorough descriptions of important areas of research and development in cancer therapeutics and cancer vaccines

Focused analysis of the global prevalence of cancer: incidence, mortality and survival rates as they relate to new directions in cancer research

Company briefs of stakeholders and companies active in cancer therapy R&D

Over 145 tables/graphs analyzing the current and future market, disease incidence and R&D pipelines for cancer therapeutics

Presentation and analysis of clinical data underscoring success of key therapies

Market share data for leading companies and products in the field

Profiles of leading products in the major cancer markets and analysis of their market impact

What makes this report topical?

Increasing need for healthcare and pharmaceutical cost-containment in both public and private spheres

Focus on introduction of standards in healthcare

Rising involvement of patients in their own healthcare and rising demand for higher quality care

Increasing use of information technology (IT) in healthcare, which provides easier access to various data and analysis

Large investments in new medical technologies and pharmaceuticals requiring high prices, rendering publicly-funded pharmaceutical reimbursement highly desirable

Unique features of this report

Thorough descriptions of key evidence-based medicine practices in major global medical and pharmaceutical markets

Discussion of evidence-based medicine's future from the point of view of medical advances, not just practical considerations

Analysis of evidence-based medicine from the point of view of pharmaceutical reimbursement

Critical assessment of evidence-based medicine's advantages and disadvantages

To order this report:

Cancer Therapeutics: Market Insight & Pipeline Analysis

http://www.reportlinker.com/p0158345/Cancer-Therapeutics-Market-Insight--Pipeline-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds The Global Antibacterials Market...
S
Study Suggests Dentists Can Identify Patients at R...